Physician profile
Daniel T Rose
NPI 1205828886
$31,559.26
in general payments reported to CMS, 2019-2025
12 companies · $4,883 in 2025
The $4,883 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $224 · 2021: $4,620 · 2022: $1,152 · 2023: $652 · 2024: $4,645 · 2025: $4,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,776 · Food and Beverage: $2,564 · Consulting Fee: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,775.64 |
| Food and Beverage | $2,564.01 |
| Consulting Fee | $840.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $15,468.47 | 2019-2020 | |
| Medtronic, INC. | $7,307.36 | 2021-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Endoskeleton Tl Nanolock Surface Technology, Mazor X System |
| Alphatec Spine, INC | $7,084.85 | 2024-2025 | Other - Miscellaneous, Lif |
| Globus Medical, INC. | $562.94 | 2021-2023 | Orbit-R Anterior Lumbar Disc |
| Nuvasive, INC. | $424.03 | 2021-2022 | |
| Trackx Technology, INC. | $338.48 | 2025 | |
| Cerapedics INC. | $137.58 | 2022 | |
| Linvatec Corporation | $97.84 | 2020 | |
| Depuy Synthes Sales INC. | $54.94 | 2023 | Conduit |
| Stryker Corporation | $40.92 | 2020 | |
| Radius Health, INC. | $29.31 | 2021 | |
| Orthofix Medical, INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.